We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Did say......lots more to come. 400p first target.
This recent news from a Company, which may have an inferior product, in terms of quality and cost, is
going to put Aortech in the limelight.
I believe there only Aortech and Foldax in the running and the market is large enough for others.
From our latest update we know further news is due next month.
https://www.biospace.com/article/releases/foldax-inc-successfully-completes-first-in-human-use-of-next-generation-tria-polymer-heart-valve-for-the-treatment-of-aortic-valve-disease/
We can anticipate good news of the steady progress, low cash burn variety.
However something dramatic cannot be ruled out.
I am not suggesting an implant of a heart valve, that is some way off yet.
Excellent update out. Plenty for the market to absorb. Good to see:
- well managed cash burn, demonstrating the value of the established licence income stream
- new key employee supported by government grant
- establishment of two new clean rooms for trial manufacturing of grafts and patches
- industry advances and recognition in polymer heart valve development which is Aortech’s ultimate holy grail
The market hasn’t a clue about the potential value underlying this company!
Nice to see some growth back to where we were.
Still a way to go though but looks like people are finally waking up
Seller clear and this moves fast, very hard to buy with the low free float....squeeze on the way.
Looks like buying through Walker Crips large holding increasing in size, with Milton clear this could really start to move towards that broker note of 400p. Long way to go upwards until fair value.
Milton sold their last shares and completely out now.
Delayed trade ending 071 matches Milton holding. Seller out this could fly in the coming weeks
Looks a bit leaky to me.
Yep something's afoot here....
Heavy activity this AM. Up 21%.
Miton have been selling down recently so maybe that last flurry of 50k’s was them clearing out? MM’s busy on the bid since then.
You were saying......
Expect further fall tomorrow imho
Try these:
- Stupidly oversold, RSI under 10!!
- Final results and update expected mid-July, so one or two buying ahead of that after a spell of barely no trades in the stock for a month.
- Possibly expect updated research from the new broker, Shore Capital, who took over Stockdale Securities recently?
- Huge upside potential remains in place and the market has given the company zero credit given that, to date, there has been no change to expectations to timelines. Last update in May contained plenty of positives and indications the company is transitioning to the manufacturing and testing stages soon.
Any other views?
good question?
A lot of movement here today...any ideas on what is driving it?
I was impressed by the progress they were making on all fronts
when they updated us on 24th January.
Over two months since that update, given they are not hanging about,
more news cannot be far off.
Now we're seeing some growth... What's driving it?
Anyone left in this share? Given the recent move up from stupidly low levels, I am surprised no holders are posting their thoughts.
House Broker updated last week following the industry news that the US FDA has granted an IDE ("investigative device exemption") to a US based company for early trials on a polymer heart valve. This gives validation to AOR's polymer valve and triggers a slow realization to the heart valve majors that their industry is changing from the old animal tissue world that they have gorged on for the last few decades.
Could be a matter of time before the companies with these new developments get snapped up by competing majors as the R&D progresses.
Broker summary was:
"We view positively the news earlier this week that the FDA has granted Foldax Inc. investigative device exemption (IDE) approval for an Early Feasibility Study of its Tria surgical aortic heart valve to treat aortic valve disease. This is because it sets the path to commerciality for AorTech with its polymeric heart valve, which uses its patented Elast-Eon polymer. With milestones set to be achieved in both the heart valve and textiles projects in 2019 and 2020, we expect to see a significant increase in news flow. We retain our 400p TP and Buy rating."
Hope you are still holding Allie123..! 43.4p to mid-price 60p in a month and a half is not too shabby. The big test is not to follow the sellers who bank short term profits (and often losses) as they have no patience. This is a share for the long term with massive upside potential and I am holding on for that.
The house broker has 400p pencilled in (possibly for this year) for starters and so far the strategy of the company is on track with both the RUA and VFT partnerships working well.
Worth digging around here as there is a lot of data to absorb. It's a long term project. Nothing is guaranteed obviously.
Interesting day...
Encouraging update indeed plus another US patent thrown in for good measure!Bill Brown is undoubtedly excited about the future here.
RNS reads well should be back on a few radars at this price
Is back on my radar.
See you soon.
Should be a good move Allie123.
A lot of disappointed momentum followers seem to be bailing out through impatience with the company’s timelines. The market makers are dropping the price of fishing nets each day but still catching the booty!
2,500 initial entry @ 43.4 (showing as a sell) looking forward to the next RNS :))
Support st these levels, news soon will see a significant rebound in my view - Happy Xmas and good luck all holders